Edwards' SAPIEN 3 Ultra Transcatheter Heart Valve Receives FDA Approval

IRVINE, Calif., Dec. 28, 2018 -- (Healthcare Sales & Marketing Network) -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced that the SA... Devices, Interventional, Cardiology, FDA Edwards Lifesciences, SAPIEN 3 Ultra, transcatheter, aortic valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news